Advertisement
PHG vs RYLPF
Which Stock Would AI Choose? Koninklijke Philips N.V. (PHG) vs. Koninklijke Philips N.V. (RYLPF) Stock Comparison
Key Takeaways
- Both PHG and RYLPF represent shares of Koninklijke Philips N.V., a global leader in health technology focused on diagnosis, treatment, and personal health solutions.
- PHG trades on the NYSE with significantly higher liquidity and average daily volume in the millions, while RYLPF is an OTC listing with minimal volume around 700 shares.
- Recent performance reflects stability around $26, following a Q4 2025 earnings-driven peak near $33, supported by strong order intake and sales growth.
- FDA clearances for innovative products like the Smart Fit TorsoCardiac coil and Bridge Plus Occlusion Balloon have bolstered positive market sentiment in recent weeks.
- Tickeron's AI analysis indicates PHG as the preferable short-term option over RYLPF due to better price momentum and accessibility.
- Both offer a dividend yield near 4%, with an ex-date approaching on May 13, 2026.
Introduction
This comparison examines PHG and RYLPF, dual listings for Koninklijke Philips N.V., highlighting differences in trading venues, liquidity, and investor access. Health technology investors and active traders may find value in understanding these nuances, particularly amid recent product innovations and recovering sector momentum. With both stocks reflecting Philips' strong Q4 results and ongoing FDA approvals, this analysis aids in evaluating relative performance, market positioning, and suitability for portfolios focused on medical devices and AI-driven diagnostics.
PHG Overview and Recent Performance
Koninklijke Philips N.V. (PHG), listed on the NYSE as an ADR, operates in healthcare segments including diagnosis & treatment, connected care, and personal health. The company has navigated past challenges like recalls but demonstrated resilience with Q4 2025 comparable sales growth of 7% and order intake up 7%, driving shares to a 52-week high near $33. In recent market activity, the stock has stabilized around $26, supported by FDA 510(k) clearances for products like the Smart Fit TorsoCardiac coil and Bridge Plus Occlusion Balloon. Trading volume remains robust, reflecting strong institutional interest, while a beta of approximately 0.92 indicates moderate volatility relative to the market. Positive sentiment stems from accelerating organic growth and AI integration in imaging.
RYLPF Overview and Recent Performance
RYLPF, the OTC Pink listing for Koninklijke Philips N.V., mirrors the core business in health technology across diagnosis, treatment, and personal health. Sharing the same fundamentals, it benefited from Q4 2025 sales and orders momentum, with shares peaking similarly before settling near $25.50 in recent weeks. Key developments include launches like Rembra CT at ECR 2026 and FDA approvals for advanced imaging and therapy tools, enhancing long-term growth prospects. However, low average volume of 700 shares limits liquidity, contributing to wider spreads and less frequent trading. Market cap hovers at $24.3 billion, PE ratio (price-to-earnings) at 23.4, and dividend yield at 3.97%, aligning closely with PHG amid stabilizing price action.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases a curated selection of top-performing AI trading bots from its library of over 350, optimized for current market conditions across thousands of tickers. Only the most effective bots—featuring win rates from 51% to 88%, annualized returns spanning +23% to +163%, profit factors up to 11.7, and profit-to-drawdown ratios as high as 17—earn a spot among the 25 trending ones. These bots employ diverse strategies like trend following, swing trading, and AI/ML agents with risk controls such as 3% take-profit/2% stop-loss corridors, targeting sectors from semiconductors to healthcare. Traders can explore these for automated insights; visit the page to review performance stats and copy top performers suited to volatile environments.
Head-to-Head Comparison
Business models are identical, centered on health technology innovation, with growth drivers including AI-enhanced diagnostics and medtech recovery. Recent momentum shows parallel price stabilization post-earnings peak, though PHG exhibits slightly stronger short-term upside per AI models. Risk factors, such as regulatory hurdles and supply chain issues, apply equally, but RYLPF’s OTC status amplifies liquidity risk with thin volume versus PHG’s NYSE advantages. Both maintain sector exposure to healthcare equipment, positive sentiment from product catalysts, and trade-offs in accessibility—PHG for institutional traders, RYLPF for niche OTC strategies. Market caps align near $25 billion, with comparable betas underscoring similar volatility profiles.
Tickeron AI Verdict
Tickeron’s AI currently favors PHG over RYLPF, citing superior short-term trend consistency, higher liquidity, and NYSE positioning for better execution amid recent stability and catalysts like FDA approvals. While fundamentals are shared, PHG’s accessibility enhances relative appeal for momentum plays, though RYLPF may suit specific low-volume preferences.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To understand the difference between Koninklijke Philips N.V. - ADR (PHG) vs. Royal Phillips NV (RYLPF) it is enough to know the definitions of ADR
ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PHG’s FA Score shows that 1 FA rating(s) are green whileRYLPF’s FA Score has 1 green FA rating(s).
- PHG’s FA Score: 1 green, 4 red.
- RYLPF’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PHG’s TA Score shows that 4 TA indicator(s) are bullish while RYLPF’s TA Score has 4 bullish TA indicator(s).
- PHG’s TA Score: 4 bullish, 5 bearish.
- RYLPF’s TA Score: 4 bullish, 4 bearish.
Price Growth
PHG (@Medical/Nursing Services) experienced а +4.01% price change this week, while RYLPF (@Medical/Nursing Services) price change was +5.56% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.45%. For the same industry, the average monthly price growth was +0.28%, and the average quarterly price growth was -6.59%.
Reported Earning Dates
PHG is expected to report earnings on Jul 28, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.45% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| PHG | RYLPF | PHG / RYLPF | |
| Capitalization | 25.9B | 25.9B | 100% |
| EBITDA | 2.68B | 2.68B | 100% |
| Gain YTD | 0.480 | 2.271 | 21% |
| P/E Ratio | 23.16 | 22.92 | 101% |
| Revenue | 17.6B | 17.6B | 100% |
| Total Cash | 2.59B | 2.59B | 100% |
| Total Debt | 8.1B | 8.1B | 100% |
PHG | RYLPF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 76 | 76 | |
PRICE GROWTH RATING 1..100 | 59 | 59 | |
P/E GROWTH RATING 1..100 | 99 | 99 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RYLPF's Valuation (4) in the null industry is in the same range as PHG (5) in the Electronic Production Equipment industry. This means that RYLPF’s stock grew similarly to PHG’s over the last 12 months.
RYLPF's Profit vs Risk Rating (100) in the null industry is in the same range as PHG (100) in the Electronic Production Equipment industry. This means that RYLPF’s stock grew similarly to PHG’s over the last 12 months.
RYLPF's SMR Rating (76) in the null industry is in the same range as PHG (76) in the Electronic Production Equipment industry. This means that RYLPF’s stock grew similarly to PHG’s over the last 12 months.
RYLPF's Price Growth Rating (59) in the null industry is in the same range as PHG (59) in the Electronic Production Equipment industry. This means that RYLPF’s stock grew similarly to PHG’s over the last 12 months.
RYLPF's P/E Growth Rating (99) in the null industry is in the same range as PHG (99) in the Electronic Production Equipment industry. This means that RYLPF’s stock grew similarly to PHG’s over the last 12 months.
| PHG | RYLPF | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 77% | 4 days ago 57% |
| Stochastic ODDS (%) | 4 days ago 61% | 4 days ago 49% |
| Momentum ODDS (%) | 4 days ago 63% | 4 days ago 52% |
| MACD ODDS (%) | 4 days ago 67% | 4 days ago 57% |
| TrendWeek ODDS (%) | 4 days ago 59% | 4 days ago 51% |
| TrendMonth ODDS (%) | 4 days ago 60% | 4 days ago 56% |
| Advances ODDS (%) | 6 days ago 62% | 5 days ago 45% |
| Declines ODDS (%) | 13 days ago 64% | N/A |
| BollingerBands ODDS (%) | 4 days ago 66% | 4 days ago 58% |
| Aroon ODDS (%) | 4 days ago 61% | 4 days ago 56% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CLCV | 28.62 | 0.14 | +0.50% |
| Crossmark Large Cap Value ETF | |||
| SPHY | 23.47 | 0.07 | +0.30% |
| State Street® SPDR® Port Hi Yld Bd ETF | |||
| SPCX | 21.98 | N/A | N/A |
| SPAC and New Issue ETF (The) | |||
| IXP | 125.00 | -0.09 | -0.07% |
| iShares Global Comm Services ETF | |||
| BSSX | 25.74 | -0.07 | -0.27% |
| Invesco BulletShares 2033 Muncpl Bd ETF | |||
PHG and
Correlation & Price change
A.I.dvisor indicates that over the last year, PHG has been loosely correlated with RYLPF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then RYLPF could also see price increases.
| Ticker / NAME | Correlation To PHG | 1D Price Change % | ||
|---|---|---|---|---|
| PHG | 100% | +0.18% | ||
| RYLPF - PHG | 56% Loosely correlated | N/A | ||
| GEHC - PHG | 53% Loosely correlated | +3.47% | ||
| ALC - PHG | 49% Loosely correlated | -2.07% | ||
| CNMD - PHG | 46% Loosely correlated | -3.52% | ||
| ENOV - PHG | 42% Loosely correlated | -2.68% | ||
More | ||||
RYLPF and
Correlation & Price change
A.I.dvisor indicates that over the last year, RYLPF has been loosely correlated with PHG. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RYLPF jumps, then PHG could also see price increases.
| Ticker / NAME | Correlation To RYLPF | 1D Price Change % | ||
|---|---|---|---|---|
| RYLPF | 100% | N/A | ||
| PHG - RYLPF | 56% Loosely correlated | +0.18% | ||
| SNNUF - RYLPF | 21% Poorly correlated | N/A | ||
| RDGL - RYLPF | 8% Poorly correlated | -7.50% | ||
| RSCF - RYLPF | 5% Poorly correlated | +4.52% | ||
| SAFLY - RYLPF | 1% Poorly correlated | N/A | ||
More | ||||